clinicalomicsprowebdirectory
Facebook
Linkedin
Twitter
News
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Search
Facebook
Linkedin
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Inside Precision Medicine
News
Coronavirus
COVID-19 Raises Risk of Heart Attack, Stroke, and Death up to…
News & Features
Antiviral Enzymes Implicated in Bladder Cancer
Molecular Dx
Innovative Blood Test Validated for Comprehensive Early Alzheimer’s Diagnosis
News & Features
Does Multiple Sclerosis Increase Cancer Risk?
News & Features
Young Adult Colorectal Cancer May Be Caused by High Blood Sugar
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Inside Precision Medicine
Innovative Blood Test Validated for Comprehensive Early Alzheimer’s Diagnosis
Hematologic tests
Molecular Dx
Innovative Blood Test Validated for Comprehensive Early Alzheimer’s Diagnosis
October 10, 2024
0
Molecular Dx
Blood Test Predicts Outcomes in Newly Diagnosed Metastatic Prostate Cancer
Laura Cowen
October 9, 2024
0
Molecular Dx
New Blood Test Predicts Risk for COPD and Severe Respiratory Diseases
September 11, 2024
0
News & Features
Opportunistic PSA Testing Drives European Prostate Cancer Overdiagnosis
September 5, 2024
0
News & Features
Blood Test to Measure Inflammation and Lipids Predicts 30-Year Cardiovascular Risks for Women
September 4, 2024
0
Molecular Dx
Biosensor Can Detect Heart Failure Biomarkers from One Drop of Saliva
August 19, 2024
0
News & Features
Common Blood Tests May Improve Cancer Risk Prediction in People with Abdominal Symptoms
Laura Cowen
July 31, 2024
0
Molecular Dx
Guardant’s Shield Colorectal Cancer Blood Test Clears FDA Panel
May 29, 2024
0
Molecular Dx
Combining Blood Test with Clinical Score Offers Breakthrough for Stroke Detection
May 17, 2024
0
Molecular Dx
Studies Find Blood Proteins That May Predict Cancer Seven Years before It Is Diagnosed
May 15, 2024
0
1
2
3
...
7
Page 1 of 7
Related Content
Blood Test Predicts Outcomes in Newly Diagnosed Metastatic Prostate Cancer
Corinna Singleman Chats with Smita Saxena
Clinical Trial Shows Synthetic THC Reduces Agitation in Alzheimer’s Disease
Anti-Inflammatory Marker Holds Promise for Cardiovascular Vaccine
Inside Precision Medicine
![Pharmaceutical manufacturers have found that using companion diagnostics during drug development improves the success rate of therapeutics being tested in clinical trials. [iStock/anna1311]](https://www.insideprecisionmedicine.com/wp-content/uploads/2019/01/355.jpeg "Common Blood Tests May Improve Cancer Risk Prediction in People with Abdominal Symptoms")
